Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in... see more

Recent & Breaking News (TSXV:VPT)

Ventripoint Announces Filing of Articles of Amendment

TheNewsWire January 13, 2021

Ventripoint Issues Option Grants

TheNewsWire January 13, 2021

Ventripoint Expands to Address the Needs of Companion Animals

TheNewsWire January 11, 2021

Kings College London Receives VMS+3.0 Ventripoint Whole Heart Analysis System

TheNewsWire January 4, 2021

Ventripoint Diagnostics Reports Results of Annual General & Special Shareholders Meeting

TheNewsWire December 15, 2020

Ventripoint Diagnostics Receives Loan from FedDev Regional Relief and Recovery Fund and Reminds Shareholders about Annual General Meeting Today

TheNewsWire December 14, 2020

Ventripoint Diagnostics Receives Wage Subsidy

TheNewsWire December 10, 2020

Ventripoint Diagnostics Issues Shares in Payment of Debenture Interest, Consulting Fees and DSU Exercise

TheNewsWire November 26, 2020

Canada's Largest Cardiac Centre Receives VMS+3.0 Ventripoint Whole Heart Analysis System

TheNewsWire November 5, 2020

Ventripoint Engages Oak Hill Financial to Provide Investor Relations Services and Approval of Warrant Amendment

TheNewsWire November 3, 2020

Ventripoint Makes Application to Amend Warrrants

TheNewsWire October 9, 2020

Ventripoint Installs Whole Heart Analysis System in MD Anderson Cancer Center in Houston

TheNewsWire October 8, 2020

Ventripoint Announces Appointment to the Board of Directors and Option Grants

TheNewsWire September 30, 2020

Ventripoint Remotely Installs Whole Heart Analysis System in Major European Hospital

TheNewsWire September 28, 2020

Correction: Options at exercise price of $0.10. Ventripoint Engages Torrey Hills Capital to Provide Investor Relations Services

TheNewsWire September 25, 2020

Ventripoint Engages Torrey Hills Capital to Provide Investor Relations Services

TheNewsWire September 25, 2020

IIROC Trading Resumption - VPT

Canada NewsWire September 24, 2020

Ventripoint To Resume Trading at the Market Opening Friday, September 25, 2020

TheNewsWire September 23, 2020

Ventripoint Provides Corporate Update and Enters Review by TSXV to Resume Trading

TheNewsWire September 15, 2020

Ventripoint Announces Closing of Second Tranche of Non-Brokered Secured Convertible Debenture Unit Private Placement

TheNewsWire September 14, 2020